Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FenicsBio is a biotechnology company specializing in functional genomics tools and services designed to accelerate drug discovery and biological research. The company provides a comprehensive suite of products, including CRISPR/Cas9 genome editing tools, RNAi reagents, and viral delivery systems such as lentivirus and AAV. FenicsBio also offers specialized services in stable cell line generation, custom viral vector production, and library screening. By providing high-quality reagents and expert technical support, the company enables researchers to perform precise genetic manipulations and functional screens. Their offerings are widely used in academic and industrial laboratories for target identification and validation. The company is headquartered in Milpitas, California, and serves a global customer base in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FenicsBio.